Texas judge rules ACA unconstitutional

A Texas judge has ruled the Affordable Care Act unconstitutional in its entirety, throwing the American healthcare system into an uncertain future.

The ruling stems from a lawsuit launched by 20 Republican governors and attorneys general that argued because the tax penalty provision of the healthcare law had been reduced to zero in 2017, the law was no longer constitutional. The Department of Justice, which is generally tasked with defending the law, took the extraordinary step of largely agreeing with the plaintiffs in the case and stated it would not defend the ACA in the case.

The judgment, handed down on Friday, Dec. 14, overturns the ACA, including its many popular provisions, such as protections for those with pre-existing conditions and allowing young people to stay on their parents’ insurance plans until they are 26. More than 100 million people could be impacted by the pre-existing conditions provision alone if the ruling stands.

"In sum, the Individual Mandate 'is so interwoven with [the ACA's] regulations that they cannot be separated. None of them can stand,'" U.S. District Court Judge Reed O'Connor wrote in his judgment.

While the judge’s ruling is clear, the case will be appealed by California, and the White House and CMS have stated the ACA will remain as current law until the appeals process has been completed.

“The recent federal court decision is still moving through the courts and the work of the Innovation Center will continue unchanged,” CMS wrote in a statement. “We remain committed to our current and future models as well as our focus on better health outcomes at lower cost.”

President Trump was enthusiastic about the news.

“Wow, but not surprisingly, ObamaCare was just ruled UNCONSTITUTIONAL by a highly respected judge in Texas. Great news for America!” he tweeted on Friday.

Trump further stated Republicans now have a chance to pass a better healthcare law. However, Republican failed to pass their plan, the American Health Care Act, in 2017, and attacks to the ACA have so far died out in Congress.

Friday’s decision was immediately met with significant backlash from industry stakeholders, including the American Medical Association, which will work on appeal efforts.

"Today’s decision is an unfortunate step backward for our health system that is contrary to overwhelming public sentiment to preserve pre-existing condition protections and other policies that have extended health insurance coverage to millions of Americans,” AMA President Barbara L. McAneny, MD, said in a statement. “It will destabilize health insurance coverage by rolling back federal policy to 2009. No one wants to go back to the days of 20 percent of the population uninsured and fewer patient protections, but this decision will move us in that direction.”

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.